Mixtard 30 Flexpen (3ml Each)
Marketer
Novo Nordisk India Pvt Ltd
Salt Composition
Insulin Isophane (70%) + Human insulin (30%)
Overview Mixtard 30 Flexpen (3ml Each)
NovoMix 30 FlexPen (3ml vials) combines fast- and intermediate-acting insulins for managing type 1 and type 2 diabetes in adults and children. This insulin helps regulate blood glucose, typically used alongside other diabetic medications as directed by your healthcare provider. Subcutaneous injection is recommended, administered 15 minutes prior to or within 20 minutes after meals. Discontinue use only under your doctor's guidance. This medication is part of a comprehensive plan including diet, exercise, and weight management as advised by your physician. Regular blood glucose monitoring and result tracking are crucial for dose adjustment. Hypoglycemia (low blood sugar) is a common side effect; maintaining consistent meals, accurate dosing, and regular blood sugar checks minimize this risk. Excessive alcohol consumption can also contribute to low blood sugar. Injection site reactions (redness, swelling) are possible, as are weight gain, rash, edema, and itching. Avoid use with existing hypoglycemia. Inform your doctor of any kidney, liver, or heart conditions before commencing treatment. Pregnant or lactating individuals should discuss dosage adjustments with their physician.
Uses of Mixtard 30 Flexpen (3ml Each)
Managing Diabetes Mellitus
Major Benefits of Mixtard 30 Flexpen (3ml Each):
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Mixtard 30 Flexpen (3ml Each):
- Hypoglycemia (low blood glucose level)
- Injection site reactions (pain, swelling, redness)
- Weight gain
How to use Mixtard 30 Flexpen (3ml Each):
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Mixtard 30 Flexpen (3ml Each) works:
Isophane insulin offers extended action, in contrast to the rapid onset of human insulin. Their combined use achieves sustained blood glucose management through enhanced sugar uptake into muscle and fat tissue and reduced hepatic glucose output.
SAFETY ADVICE
AlcoholUNSAFE
Combining Mixtard 30 Flexpen (3ml vials) with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
Using Mixtard 30 Flexpen (3ml vials) during pregnancy is typically regarded as safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Using the insulin product Mixtard 30 Flexpen (3ml vials), while breastfeeding, presents minimal risk. Research in humans indicates negligible transfer into breast milk, posing no apparent threat to the infant.
DrivingCAUTION
Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Mixtard 30 Flexpen (3ml vials) cautiously. Dosage modification of Mixtard 30 Flexpen (3ml vials) might be necessary. Physician consultation is advised. Routine blood glucose level checks are suggested to guide dosage changes.
LiverCAUTION
Patients with liver impairment should use Mixtard 30 Flexpen (3ml vials) cautiously, as dose modification may be necessary. Consult your physician for guidance. Routine glucose monitoring is advised to optimize dosage.
What if you forget to take Mixtard 30 Flexpen (3ml Each) :
Forgetting a dose of your Mixtard 30 Flexpen (3ml) insulin can lead to elevated blood glucose (hyperglycemia). Measure your blood sugar and adjust your subsequent injection accordingly.
Facts to Know About Mixtard 30 Flexpen (3ml Each)
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes medication |
3,018 People bought this recently